This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Five Dumbest Things on Wall Street This Week: Oct. 26

Stocks in this article: AIG AMD GS MNST ZNGA AAPL

3. Goldman's Conviction

What's the difference between a "buy" and a "conviction buy" at Goldman Sachs?

Well, as far as we can tell from its maneuvers in Monster Beverage Corp. (MNST - Get Report) this week, it literally is "conviction" in both senses of the word.

Bear with us.

Shares of the beverage maker, which sells super-caffeinated drinks such as Java Monster, Monster Rehab, and X-Presso Monster, sank 10.5% to $41 Tuesday, after Goldman analyst Judy Hong yanked the company from its high-profile conviction buy list. Hong made the move after the Food and Drug Administration announced Monday that it was investigating reports of five deaths linked to the company's drinks.

Monster is also being sued by the family of a 14-year-old Maryland girl with a heart condition who tragically died after drinking two cans of Monster in a single day. For those unfamiliar with Monster's eponymous energy drink, it comes in 24-ounce cans and contains 240 milligrams of caffeine, or about seven times the amount of the caffeine in a 12-ounce can of regular Coke. (Oh man! We get a headache just thinking about it.)

Not that Hong's conviction has helped the shares that much. Since she added it to the conviction list on January 16, Monster's stock had fallen 5.7% vs. an 11.2% surge in the S&P 500.

"While the FDA has yet to establish a causal link between these deaths and the drink, we believe MNST shares could be range-bound in the near term," analyst Judy Hong wrote in the note. She did, however, maintain a "buy" rating on the stock, saying that following Monster's massive selloff, regulatory and legal risks are already baked into the stock's price.

As to the difference between a "buy" and a "conviction buy," we guess it has something to do with emphasis, but to be honest it seems purely semantic to us.

For that matter, the Monster downgrade, if that's what it was, seems to be a matter of semantics as well. According to Hong's logic, if the Maryland girl's family fails to get a conviction in its case against the company, then Hong will get her conviction back in the stock.

You know what? Simply thinking about that notion gives us an even bigger headache.

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs